Bain Capital Life Sciences Fund II, L.P.

Q3 2024 13F Notice

Signature - Title
Adam Koppel - Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Holdings as of
September 30, 2024
Date filed
11/14/2024, 07:01 AM
Description
No holdings are reported in this report, and all US holdings are reported by other reporting manager(s). The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.

Bain Capital Life Sciences Fund II, L.P. didn't report any stock holdings as of Q3 2024.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Adam Koppel Partner of Bain Capital Life Sciences Investors, LLC Boston, Massachusetts 11/14/2024

The report on Form 13F for the period ended September 30, 2024 for Bain Capital Life Sciences Fund II, L.P. (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the manager of Bain Capital Life Sciences Investors II, LLC, which is the general partner of the Fund.

List of Other Managers Reporting for Bain Capital Life Sciences Fund II, L.P.:

Name Holdings Value Location File Number
Bain Capital Life Sciences Investors, LLC $961M Boston, MA 028-18477
Bain Capital Life Sciences Investors II, LLC Boston, MA 028-20816